Skip to content
Translational Neuropharmacology Lab (Zanos Lab)

Translational Neuropharmacology Lab (Zanos Lab)

Our laboratory, based in Cyprus, employs molecular and systems neuroscience, behavioral pharmacology, as well as advanced computational methods to unravel the mysteries of brain diseases and identify targets for the development of novel and effective pharmacotherapies.

Menu
  • Home
  • News
  • Team Members
    • Lab Director
    • Current Team Members
    • Alumni
  • Research
  • Research Units
    • Translational Neuropharmacology Unit
    • Clinical Neuropsychopharmacology Unit
    • AI & Systems Bioinformatics Unit Cyprus
    • Genetic Epidemiology Unit
  • Facilities
  • Publications
  • Media
  • Join Us
  • Contact
  • More

Category: News

News

Infrastructure grant awarded to the Zanos Lab: TRACER Research Center

No Comments
| News

The Zanos Lab is proud to announce the award of €500,000 from the Research Promotion Foundation of Cyprus to establish the Translational Neuroscience and Behavioural Pharmacology Research Center (TRACER). This infrastructure grant will establish Cyprus’s first comprehensive neuropharmacology and systems neuroscience research facility, positioning our laboratory and the University of Cyprus at the forefront of […]

Read More »

Dr. Andria Michael brings Neuroimmunology to young minds

No Comments
| News

We’re excited to share that our postdoctoral researcher Dr. Andria Michael has authored an insightful article in Neolaia, Cyprus’s youth newspaper, explaining the fascinating connection between the immune system, neuroscience and depression. In her piece titled “How Does the Immune System Connect with Depression?”, Dr. Michael breaks down complex neurobiological concepts for young readers, exploring […]

Read More »

Exploring Misophonia via identifying innovative biomarkers

No Comments
| News

Our Ph.D. student, Ms. Despina Melanthiou presented her research project on identifying novel biomarkers for misophonia. Her work, that is being conducted at the University of Cyprus, explores the use of electroencephalography (EEG), heart rate variability (HRV), and other neuropsychophysiological markers, alongside biological markers from blood samples, to better understand this complex sensory processing disorder. […]

Read More »

New preprint: Transcriptomic insights into (2R,6R)-hydroxynorketamine’s possible therapeutic effects for Opioid Use Disorder

No Comments
| News

We are excited to share our latest research led by Dr. Anna Onisiforou with contributions from Dr. Andria Michael and Mr. Morfeas Koumas now available as a preprint on bioRxiv, titled “Transcriptomic mapping of the ventral hippocampus reveals (2R,6R)-hydroxynorketamine as a potential therapeutic agent for opioid abstinence.” This study investigates the therapeutic potential of (2R,6R)-hydroxynorketamine (HNK), a […]

Read More »

Dr. Apostolakis Shares Specialized Research Insights on Nicotine Addiction at European Psychology Congress Workshop

No Comments
| News

The Translational Neuropharmacology Lab is proud to announce that Dr. Apostolakis delivered a compelling presentation at the 19th European Congress of Psychology, held July 1-4, 2025, in Paphos, Cyprus. His research presentation, “Stress biomarkers and emotion regulation difficulties as predictive factors of vulnerability to nicotine addiction relapse,” highlighted groundbreaking findings in the field of smoking […]

Read More »

Dr. Zanos receives the 2025 Research Excellence Award from the University of Cyprus

No Comments
| News

We are excited to announce that Dr. Zanos, the Director of the Translational Neuropharmacology Laboratory, has been honored with the prestigious 2025 Research Excellence Award from the University of Cyprus. The award, presented by the Minister of Education of Cyprus on June 25, 2025, recognizes Dr. Zanos’ and our lab’s groundbreaking contributions to neuroscience and […]

Read More »

Dr. Zanos meets Prof. George Paxinos at the Mediterranean Neuroscience Society 2025 conference

No Comments
| News

We’re excited to share a special moment from the 10th Mediterranean Neuroscience Society Conference 2025 in Crete, Greece. Our lab director had the incredible opportunity to meet Professor George Paxinos AO, one of the most influential figures in modern neuroscience. Professor Paxinos is universally recognized as “the man who mapped the brain.” He’s the author […]

Read More »

Dr. Zanos chairs ketamine research symposium at the Mediterranean Neuroscience Society conference 2025

No Comments
| News

Dr. Panos Zanos represented our lab at the Mediterranean Neuroscience Society Conference in Crete, where he chaired a symposium on ketamine’s rapid antidepressant mechanisms. The symposium, titled “Unraveling ketamine’s rapid antidepressant mechanisms: From neural circuits to clinical implications,” brought together leading researchers from around the world to discuss cutting-edge findings on how ketamine works as […]

Read More »

Dr. Michael presents new research on the potential efficacy of ketamine’s metabolite hydroxynorketamine for opioid addiction

No Comments
| News

Dr. Michael (Marie Curie fellow from our lab) presented new research at the Mediterranean Neuroscience Society Conference in Crete, showcasing our latest findings on how a ketamine metabolite could help treat opioid addiction. Her poster focused on (2R,6R)-hydroxynorketamine (HNK), a ketamine metabolite, and its effects on opioid addiction-related behaviors in mice. The research tackled one […]

Read More »

Dr. Zanos discusses social media’s impact on the brain at Pan-Cypriot Festival of Youth and Students event

No Comments
| News

Dr. Panos Zanos delivered an engaging discussion on “Social Media & Brain” as part of the 37th Pan-Cypriot Festival of Youth and Students. The talk explored the fascinating intersection between our digital habits and neurological processes, including insights from current research on how social media platforms influence brain function, potentially covering topics such as dopamine reward […]

Read More »

Posts pagination

Previous 1 2 3 … 11 Next

Recent Posts

  • New pre-print: VirTarget framework reveals how Multiple Sclerosis immunotherapies engage with Epstein-Barr Virus-driven disease mechanisms November 6, 2025
  • New preprint: VirTrack framework reveals stage-specific EBV pathogenesis in Multiple Sclerosis October 26, 2025
  • Translational Neuropharmacology Lab presents on novel therapies for brain disorders October 25, 2025
  • Dr. Zanos was invited and presented on antidepressant mechanisms of action of ketamine and other rapid-acting antidepressants at the 6th German-Cypriot Psychotherapy Conference October 7, 2025
  • Featured in Nature Mental Health: Advancing ketamine research and brain pathology treatments October 3, 2025

Navigation

  • Home
  • News
  • Team Members
    • Lab Director
    • Current Team Members
    • Alumni
  • Research
  • Research Units
    • Translational Neuropharmacology Unit
    • Clinical Neuropsychopharmacology Unit
    • AI & Systems Bioinformatics Unit Cyprus
    • Genetic Epidemiology Unit
  • Facilities
  • Publications
  • Media
  • Join Us
  • Contact
  • More

Translational Neuropharmacology Lab (Zanos Lab) 2025 . Powered by WordPress